| FIVLX | TROZX | FIVLX / TROZX | |
| Total Expense Ratio | 0.87 | 0.00 | - |
| Annual Report Gross Expense Ratio | 0.87 | 0.66 | 132% |
| Fund Existence | 20 years | 6 years | - |
| Gain YTD | 40.557 | 43.112 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.2B | 16.7B | 19% |
| Annual Yield % from dividends | 2.11 | 2.58 | 82% |
| Returns for 1 year | 34.36 | 38.93 | 88% |
| Returns for 3 years | 76.15 | 86.45 | 88% |
| Returns for 5 years | 91.64 | 95.56 | 96% |
| Returns for 10 years | 101.92 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ARAHX | 5.93 | 0.06 | +1.02% |
| Aristotle Small/Mid Cap Equity A | |||
| IEGIX | 24.00 | 0.24 | +1.01% |
| Invesco International Small Company R5 | |||
| BAFWX | 58.26 | 0.22 | +0.38% |
| Brown Advisory Sustainable Growth I | |||
| FOCIX | 14.61 | 0.05 | +0.34% |
| Fairholme Focused Income | |||
| FBTTX | 35.41 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||